Chmiela Tomasz, Jarosz-Chobot Przemysława, Gorzkowska Agnieszka
Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
Department of Children's Diabetology and Lifestyle Medicine, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
Healthcare (Basel). 2024 Dec 6;12(23):2462. doi: 10.3390/healthcare12232462.
Parkinson's disease (PD) and type 2 diabetes mellitus (T2DM) are both age-related diseases. Evidence from recent studies suggests a link between them. The existence of an interaction between autonomic nervous system dysfunction and the dysregulation of glucose metabolism is one of the proposed mechanisms to explain the complicated relationship between these diseases. The aims of this study are to assess the incidence of glycemic dysregulation in people with PD and to identify clinical factors that may predispose patients with PD to the occurrence of metabolic disturbances. In total, 35 individuals diagnosed with PD and 20 healthy control subjects matched in terms of age and gender participated in a study consisting of clinical and biometric assessments along with 14 days of continuous glucose monitoring (CGM) using the Freestyle Libre system. In the group of patients with PD, a comparative analysis was performed between patients with and without autonomic dysfunction. The severity of autonomic dysfunction was assessed using the SCOPA-AUT. : Participants diagnosed with PD demonstrated a trend toward lower morning glucose levels compared to the control group. PD patients with autonomic symptoms had greater glucose variability and a deeper trend toward lower glucose levels in the mornings. The presence of autonomic dysfunction, especially orthostatic hypotension and micturition disturbance, and the severity of autonomic symptoms were associated with greater glycemic variability. : The occurrence of autonomic disorders in the course of Parkinson's disease predisposes patients to more profound glycemic dysregulation.
帕金森病(PD)和2型糖尿病(T2DM)都是与年龄相关的疾病。近期研究证据表明它们之间存在联系。自主神经系统功能障碍与葡萄糖代谢失调之间的相互作用是解释这些疾病复杂关系的一种提出的机制。本研究的目的是评估帕金森病患者血糖失调的发生率,并确定可能使帕金森病患者易发生代谢紊乱的临床因素。总共35名被诊断为帕金森病的个体和20名在年龄和性别上匹配的健康对照者参与了一项研究,该研究包括临床和生物特征评估以及使用Freestyle Libre系统进行的14天连续血糖监测(CGM)。在帕金森病患者组中,对有无自主神经功能障碍的患者进行了比较分析。使用SCOPA - AUT评估自主神经功能障碍的严重程度。:与对照组相比,被诊断为帕金森病的参与者表现出早晨血糖水平较低的趋势。有自主神经症状的帕金森病患者血糖变异性更大,且早晨血糖水平下降趋势更明显。自主神经功能障碍的存在,尤其是体位性低血压和排尿障碍,以及自主神经症状的严重程度与更大的血糖变异性相关。:帕金森病病程中自主神经障碍的发生使患者更容易出现更严重的血糖失调。